Analysts rate Signify Health Inc. (SGFY:NYE) with a Strong Buy rating at a $24.79 target

BTIG Research initiates Signify Health as Buy at $35 target

Based on the Signify Health stock forecast from 10 analysts, the average analyst target price for Signify Health Inc. is USD 24.79 over the next 12 months. Signify Health stock average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Signify Health stock is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, Signify Health stock price was USD 28.77. Signify Health stock price has changed by +0.77% over the past week, +10.46% over the past month and +9.60% over the last year.

About Signify Health Inc. (SGFY:NYE)

Signify is  a leading healthcare platform which  powers and establishes value controlled payment programs, which leverage advanced analytics, in cooperation with technology and country wide healthcare provider networks, Signify’s platform helps to ensure the completion of payor and provider clients with value based custom care solutions.

 

Most Recent Analyst Ratings for SGFY’s Stock:

 

 

What we like:

There is nothing we particularly like about signify health stock.

 

What we don’t like:

Poor risk-adjusted returns

This company is delivering below median risk-adjusted returns to its peers. Even if it is outperforming on returns, the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above the median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.